Skip to content

Endothelial Bleb Response With Toric Lenses

Evaluation of the Short-Term Corneal Endothelial Response to Wear of Toric Soft Contact Lenses in Asian Eyes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00630305
Enrollment
37
Registered
2008-03-07
Start date
2008-01-31
Completion date
2008-07-31
Last updated
2017-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ametropia

Keywords

toric, endothelial bleb

Brief summary

Evaluate the short-term corneal response of oxygen deprivation when using toric contact lenses. The response will be noted by endothelial bleb formation in both open eye and closed eye state.

Detailed description

Interested subjects who meet the entry criteria for the study will be scheduled for four sessions of approximately 30 minutes duration each. Informed consent obtained. Baseline measurements of visual acuity and corneal and conjunctival physiology will be recorded. An examination of the endothelium of the corneas will be conducted using the specular microscope, readings obtained at 5 locations on each cornea: one in the centre and one in each of the superior, inferior, nasal and temporal peripheral regions, approximately 2mm from the limbal margin. The assigned lenses will be inserted according to a fixed-allocation randomization schedule, where each session follows an optimized 2- period simultaneous crossover design, which specifies lenses to be used in each of the four sessions. Lenses will be worn for 20 minutes and then removed. Endothelial specular microscopy will be conducted at 20 minutes with the lenses on. A final evaluation of corneal and conjunctival physiology will be performed prior to subject clearance from the study.

Interventions

Subjects that were randomized to receive alphafilcon A toric during one of the four sessions (Sessions A, B, C and D).

Subjects that were randomized to receive lotrafilcon B toric during one of the four sessions (Sessions A, B, C and D).

Subjects that were randomized to receive senofilcon A toric during one of the four sessions (Sessions A, B, C and D).

Sponsors

Johnson & Johnson Vision Care, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

1. Successful soft contact lens wear in daily mode for a minimum of 1 month prior to start of the study without experiencing difficulties or contact lens related complications. 2. At least 18 years of age and mentally competent to sign an informed consent form. 3. Healthy eyes and no use of ocular medication. 4. Similarity of optical parameters between eyes. 5. Physical appearance typical of Asian eyes

Exclusion criteria

1. A medical or ocular condition that may influence the outcome of this trial. 2. Current use of ocular/systemic medication that may influence the outcome of this trial. 3. Failure to wear soft lenses for 2 weeks prior to the start of the study. 4. Current enrolment or participation in another clinical study. 5. Current state of pregnancy or breastfeeding 6. Anisometropia greater than 1.00D (equivalent sphere). 7. Unequal acuities between eyes (greater than 1 line) 8. Unequal corneal curvatures (\>1.00D)

Design outcomes

Primary

MeasureTime frameDescription
Endothelial Bleb Areas on Cornea: Session A- Open Eye20 minutes post-lens insertionMean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.
Endothelial Bleb Areas on Cornea: Session B- Closed Eye20 minutes post-lens insertionMean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.
Endothelial Bleb Areas on Cornea: Session C- Open Eye20 minutes post-lens insertionMean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.
Endothelial Bleb Areas on Cornea: Session D- Closed Eye20 minutes post-lens insertionMean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.

Countries

Australia

Participant flow

Recruitment details

Total of 37 subjects enrolled, with two being discontinued. Thirty-five (35) subjects were recruited to a single site, where eligibility was confirmed and informed consent discussed and when appropriate signed.

Pre-assignment details

Subjects were randomized to go to all four sessions (A, B, C and D) in a random order. Once in a session subjects were further randomized to one of four contralteral lens sequences (right eye / left eye).

Participants by arm

ArmCount
All Subjects
All subjects who were enrolled, randomized, and assigned to a study arm.
37
Total37

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyInability to insert contact lens1
Overall StudyWithdrawal by Subject1

Baseline characteristics

CharacteristicAll Subjects
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
37 Participants
Age, Continuous25.9 years
STANDARD_DEVIATION 7.7
Gender
Female
25 Participants
Gender
Male
12 Participants
Region of Enrollment
Australia
37 participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —— / —
other
Total, other adverse events
0 / 370 / 370 / 370 / 37
serious
Total, serious adverse events
0 / 370 / 370 / 370 / 37

Outcome results

Primary

Endothelial Bleb Areas on Cornea: Session A- Open Eye

Mean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.

Time frame: 20 minutes post-lens insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation. The analysis was conducted on subject eyes.

ArmMeasureGroupValue (MEAN)Dispersion
Sequence 1Endothelial Bleb Areas on Cornea: Session A- Open EyeSuperior0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 1Endothelial Bleb Areas on Cornea: Session A- Open EyeInferior0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session A- Open EyeTemporal0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session A- Open EyeNasal0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session A- Open EyeCentral0.1 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 2Endothelial Bleb Areas on Cornea: Session A- Open EyeNasal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 2Endothelial Bleb Areas on Cornea: Session A- Open EyeSuperior0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 2Endothelial Bleb Areas on Cornea: Session A- Open EyeTemporal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 2Endothelial Bleb Areas on Cornea: Session A- Open EyeInferior0.8 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 2Endothelial Bleb Areas on Cornea: Session A- Open EyeCentral2.0 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 3Endothelial Bleb Areas on Cornea: Session A- Open EyeNasal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 3Endothelial Bleb Areas on Cornea: Session A- Open EyeCentral0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 3Endothelial Bleb Areas on Cornea: Session A- Open EyeInferior0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 3Endothelial Bleb Areas on Cornea: Session A- Open EyeSuperior0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 3Endothelial Bleb Areas on Cornea: Session A- Open EyeTemporal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 4Endothelial Bleb Areas on Cornea: Session A- Open EyeSuperior0.3 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 4Endothelial Bleb Areas on Cornea: Session A- Open EyeInferior2.3 Percent Difference of Bleb AreaStandard Deviation 1
Sequence 4Endothelial Bleb Areas on Cornea: Session A- Open EyeCentral2.1 Percent Difference of Bleb AreaStandard Deviation 0.7
Sequence 4Endothelial Bleb Areas on Cornea: Session A- Open EyeNasal0.7 Percent Difference of Bleb AreaStandard Deviation 0.4
Sequence 4Endothelial Bleb Areas on Cornea: Session A- Open EyeTemporal0.4 Percent Difference of Bleb AreaStandard Deviation 0.2
Primary

Endothelial Bleb Areas on Cornea: Session B- Closed Eye

Mean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.

Time frame: 20 minutes post-lens insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation. The analysis was conducted on subject eyes.

ArmMeasureGroupValue (MEAN)Dispersion
Sequence 1Endothelial Bleb Areas on Cornea: Session B- Closed EyeSuperior0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session B- Closed EyeInferior0.5 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 1Endothelial Bleb Areas on Cornea: Session B- Closed EyeTemporal0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 1Endothelial Bleb Areas on Cornea: Session B- Closed EyeNasal0.5 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 1Endothelial Bleb Areas on Cornea: Session B- Closed EyeCentral2.0 Percent Difference of Bleb AreaStandard Deviation 0.9
Sequence 2Endothelial Bleb Areas on Cornea: Session B- Closed EyeNasal0.9 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 2Endothelial Bleb Areas on Cornea: Session B- Closed EyeSuperior0.2 Percent Difference of Bleb Area
Sequence 2Endothelial Bleb Areas on Cornea: Session B- Closed EyeTemporal0.5 Percent Difference of Bleb AreaStandard Deviation 0.2
Sequence 2Endothelial Bleb Areas on Cornea: Session B- Closed EyeInferior3.9 Percent Difference of Bleb AreaStandard Deviation 2.2
Sequence 2Endothelial Bleb Areas on Cornea: Session B- Closed EyeCentral5.9 Percent Difference of Bleb AreaStandard Deviation 2.5
Sequence 3Endothelial Bleb Areas on Cornea: Session B- Closed EyeNasal1.0 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 3Endothelial Bleb Areas on Cornea: Session B- Closed EyeCentral4.0 Percent Difference of Bleb AreaStandard Deviation 0.9
Sequence 3Endothelial Bleb Areas on Cornea: Session B- Closed EyeInferior2.5 Percent Difference of Bleb AreaStandard Deviation 0.5
Sequence 3Endothelial Bleb Areas on Cornea: Session B- Closed EyeSuperior10.3 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 3Endothelial Bleb Areas on Cornea: Session B- Closed EyeTemporal0.5 Percent Difference of Bleb AreaStandard Deviation 0.2
Sequence 4Endothelial Bleb Areas on Cornea: Session B- Closed EyeSuperior0.3 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 4Endothelial Bleb Areas on Cornea: Session B- Closed EyeInferior0.9 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 4Endothelial Bleb Areas on Cornea: Session B- Closed EyeCentral0.9 Percent Difference of Bleb AreaStandard Deviation 0.5
Sequence 4Endothelial Bleb Areas on Cornea: Session B- Closed EyeNasal0.1 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 4Endothelial Bleb Areas on Cornea: Session B- Closed EyeTemporal0.3 Percent Difference of Bleb AreaStandard Deviation 0.1
Primary

Endothelial Bleb Areas on Cornea: Session C- Open Eye

Mean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.

Time frame: 20 minutes post-lens insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation. The analysis was conducted on subject eyes.

ArmMeasureGroupValue (MEAN)Dispersion
Sequence 1Endothelial Bleb Areas on Cornea: Session C- Open EyeSuperior0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session C- Open EyeInferior0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session C- Open EyeTemporal0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session C- Open EyeNasal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 1Endothelial Bleb Areas on Cornea: Session C- Open EyeCentral0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 2Endothelial Bleb Areas on Cornea: Session C- Open EyeNasal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 2Endothelial Bleb Areas on Cornea: Session C- Open EyeSuperior0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 2Endothelial Bleb Areas on Cornea: Session C- Open EyeTemporal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 2Endothelial Bleb Areas on Cornea: Session C- Open EyeInferior0.1 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 2Endothelial Bleb Areas on Cornea: Session C- Open EyeCentral0.4 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 3Endothelial Bleb Areas on Cornea: Session C- Open EyeNasal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 3Endothelial Bleb Areas on Cornea: Session C- Open EyeCentral0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 3Endothelial Bleb Areas on Cornea: Session C- Open EyeInferior0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 3Endothelial Bleb Areas on Cornea: Session C- Open EyeSuperior0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 3Endothelial Bleb Areas on Cornea: Session C- Open EyeTemporal0.0 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 4Endothelial Bleb Areas on Cornea: Session C- Open EyeSuperior0.4 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 4Endothelial Bleb Areas on Cornea: Session C- Open EyeInferior0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 4Endothelial Bleb Areas on Cornea: Session C- Open EyeCentral0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 4Endothelial Bleb Areas on Cornea: Session C- Open EyeNasal0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 4Endothelial Bleb Areas on Cornea: Session C- Open EyeTemporal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Primary

Endothelial Bleb Areas on Cornea: Session D- Closed Eye

Mean area of endothelial blebs in the following corneal locations: Central, Nasal, Temporal, Inferior, Superior. A masked observer performed the analysis by subjectively selecting a region in a given image that provided an optimal balance of maximum area and clarity of cell outlines. Blebs were then outlined manually and the software calculated the area of blebs. The different sessions are reported showing results for each lens according to the lens worn in the contralateral (contra) eye.Open eye sessions simulated the subjects normal ocular behavior during waking hours; closed eye sessions simulated ocular activity during duration of closed eye activity, such as sleeping. Results are reported as the mean percent difference between the stated test (senofilcon A) and the control lens (alphafilcon A, lotrafilcon B), after 20 minutes of wear, for each testing scenario.

Time frame: 20 minutes post-lens insertion

Population: The analysis population consists of subjects that completed all study visits without a major protocol deviation. The analysis was conducted on subject eyes.

ArmMeasureGroupValue (MEAN)Dispersion
Sequence 1Endothelial Bleb Areas on Cornea: Session D- Closed EyeSuperior0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 1Endothelial Bleb Areas on Cornea: Session D- Closed EyeInferior0.8 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 1Endothelial Bleb Areas on Cornea: Session D- Closed EyeTemporal0.1 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 1Endothelial Bleb Areas on Cornea: Session D- Closed EyeNasal0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 1Endothelial Bleb Areas on Cornea: Session D- Closed EyeCentral1.7 Percent Difference of Bleb AreaStandard Deviation 0.6
Sequence 2Endothelial Bleb Areas on Cornea: Session D- Closed EyeNasal0.8 Percent Difference of Bleb AreaStandard Deviation 0.4
Sequence 2Endothelial Bleb Areas on Cornea: Session D- Closed EyeSuperior0.1 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 2Endothelial Bleb Areas on Cornea: Session D- Closed EyeTemporal0.2 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 2Endothelial Bleb Areas on Cornea: Session D- Closed EyeInferior1.7 Percent Difference of Bleb AreaStandard Deviation 1
Sequence 2Endothelial Bleb Areas on Cornea: Session D- Closed EyeCentral1.6 Percent Difference of Bleb AreaStandard Deviation 0.6
Sequence 3Endothelial Bleb Areas on Cornea: Session D- Closed EyeNasal0.1 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 3Endothelial Bleb Areas on Cornea: Session D- Closed EyeCentral0.5 Percent Difference of Bleb AreaStandard Deviation 0.2
Sequence 3Endothelial Bleb Areas on Cornea: Session D- Closed EyeInferior0.3 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 3Endothelial Bleb Areas on Cornea: Session D- Closed EyeSuperior0.3 Percent Difference of Bleb AreaStandard Deviation 0.2
Sequence 3Endothelial Bleb Areas on Cornea: Session D- Closed EyeTemporal0.1 Percent Difference of Bleb AreaStandard Deviation 0
Sequence 4Endothelial Bleb Areas on Cornea: Session D- Closed EyeSuperior0.1 Percent Difference of Bleb AreaStandard Deviation 0.1
Sequence 4Endothelial Bleb Areas on Cornea: Session D- Closed EyeInferior1.4 Percent Difference of Bleb AreaStandard Deviation 0.7
Sequence 4Endothelial Bleb Areas on Cornea: Session D- Closed EyeCentral3.5 Percent Difference of Bleb AreaStandard Deviation 2
Sequence 4Endothelial Bleb Areas on Cornea: Session D- Closed EyeNasal0.7 Percent Difference of Bleb AreaStandard Deviation 0.3
Sequence 4Endothelial Bleb Areas on Cornea: Session D- Closed EyeTemporal0.3 Percent Difference of Bleb AreaStandard Deviation 0.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026